GlassScriptPhysician profile
Carl Vegas
NPI 1922149988
$1,894.76
in general payments reported to CMS, 2019-2025
15 companies · $33.90 in 2025
The $33.90 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $380 · 2021: $386 · 2022: $390 · 2024: $378 · 2025: $33.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $520.85 | 2020-2024 | Certus 140 |
| Boston Scientific Corporation | $383.65 | 2019-2021 | |
| Medtronic, INC. | $229.09 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Sirtex Medical INC | $174.86 | 2024 | Sir-Spheres Microspheres |
| Medtronic Vascular, INC. | $145.53 | 2019-2020 | |
| Medical Device Business Services, INC. | $76.76 | 2020 | |
| Terumo Medical Corporation | $76.43 | 2019 | |
| Argon Medical Devices, INC. | $56.51 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $53.93 | 2020-2022 | |
| Biocompatibles, INC. | $53.22 | 2019 | |
| Stryker Corporation | $50.42 | 2022 | |
| Medtronic USA, INC. | $26.88 | 2019 | |
| Penumbra, INC. | $20.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.44 | 2019 | |
| Merit Medical Systems INC | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Vegas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.